Drug intelligence / Profile preview

Clear Eyes Bright and Moist

Development stage: Unknown
Lead developer: Prestige Consumer Healthcare
Modality: Small Molecules
Administration: Ophthalmic

Overview

Clear Eyes Bright and Moist is an over-the-counter ophthalmic solution developed and distributed by Evolan Pharma. It is a dual-action formulation containing naphazoline hydrochloride (0.005%) and hypromellose (0.30%). Naphazoline hydrochloride is a small molecule alpha-adrenergic agonist that acts as a vasoconstrictor, narrowing the blood vessels in the conjunctiva to reduce ocular redness. Hypromellose serves as a lubricant and artificial tear, providing moisture to refresh and soothe dry or irritated eyes. It is indicated for the relief of eye irritation, discomfort, and redness caused by environmental factors such as wind, sun, or dry environments.

Brand names: Clear Eyes Bright and MoistCleareyes Bright & Moist

Targets

ADRA2A (α2A)

Beyond the preview

Go deeper on Clear Eyes Bright and Moist.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clear Eyes Bright and Moist.

Explore the full profile